V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260018246 | 260017115 | 1.81 | 102 | Disease modification (D) | 2018-02-20 | 2018-02-27 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | 2 | N | 260020285 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260018247 | 260010183 | 1.66 | null | Curative (C) | 2017-05-22 | 2017-10-25 | Pemetrexed | 02 | N | 260021633 | CISPLATIN + RT |
| 260018248 | 260010193 | 1.68 | 103 | Curative (C) | null | 2016-05-05 | BLEOMYCIN | N | N | 260022515 | CYCLOPHOSPHAMIDE |
| 260018249 | 260014824 | 1.71 | null | Palliative (P) | 2018-07-25 | 2018-07-29 | Bortezomib + Panobinostat | N | null | 260023349 | DHAP - R |
| 260018250 | 260010197 | 1.78 | 82.4 | Palliative (P) | 2018-07-02 | 2018-07-02 | CYCLOPHOSPHAMIDE + VINORELBINE | N | N | 260025486 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260018251 | 260017118 | 1.71 | 74.8 | Disease modification (D) | 2017-03-21 | 2017-03-27 | GEMCITABINE + TIP | 2 | N | 260025887 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + METHOTREXATE |
| 260018252 | 260019125 | 1.83 | 89.45 | Curative (C) | 2016-02-23 | 2016-02-28 | PAC-E | N | N | 260028027 | CARBOPLATIN + ETOPOSIDE |
| 260018253 | 260014829 | 1.75 | 80 | Adjuvant (A) | 2016-07-13 | 2016-07-13 | PEMBROLIZUMAB | N | N | 260029516 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + PACLITAXEL |
| 260018254 | 260010207 | 1.79 | 77.3 | Curative (C) | 2018-09-27 | 2018-09-30 | Cyclophosphamide PO +Vinorelbine IV | 02 | N | 260029639 | IVADO |
| 260018255 | 260010210 | 1.79 | 62 | Disease modification (D) | 2016-10-26 | 2016-10-26 | Carboplatin + Etoposide IV 3 day | 2 | N | 260029897 | CARBO + THIOTEPA + TOPOTECAN |
| 260018256 | 260014832 | null | 80 | Palliative (P) | 2019-09-21 | 2019-09-21 | BLEOMYCIN + VINCRISTINE | N | N | 260000136 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260018257 | 260010216 | 1.62 | null | Curative (C) | 2019-03-15 | 2019-03-23 | NIVOLUMAB | N | N | 260003454 | DOCETAXEL + TRASTUZUMAB |
| 260018258 | 260010217 | 1.63 | 107.7 | Curative (C) | 2016-10-31 | 2016-12-23 | TRASTUZUMAB | N | N | 260006100 | CYTARABINE HD + METHOTREXATE HD |
| 260018259 | 260010223 | 1.63 | 55.6 | Palliative (P) | 2019-09-10 | 2019-09-17 | TRASTUZUMAB | 2 | N | 260007145 | TRASTUZUMAB |
| 260018260 | 260010225 | 1.79 | 75 | Curative (C) | 2017-09-04 | 2017-09-11 | Paclitaxel Priming | 02 | N | 260007252 | GDP |
| 260018261 | 260010228 | null | 59 | Palliative (P) | 2016-04-16 | 2016-04-16 | Carboplatin + Thiotepa + Topotecan | N | N | 260007814 | CARBOPLATIN + IFOSFAMIDE + PACLITAXEL |
| 260018262 | 260010232 | 1.69 | 88.3 | null | 2019-03-30 | 2019-04-05 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260009956 | VINORELBINE |
| 260018263 | 260010235 | 1.55 | 66.6 | Curative (C) | 2017-11-13 | 2017-11-20 | BLEOMYCIN + VINCRISTINE | 02 | N | 260013467 | CARBOPLATIN + PACLITAXEL |
| 260018264 | 260014846 | null | 60 | Curative (C) | 2017-05-15 | 2017-05-15 | POMB/ACE | N | N | 260015436 | CYTARABINE + METHOTREXATE HD |
| 260018265 | 260018840 | 1.73 | 74 | Curative (C) | 2019-04-03 | 2019-04-04 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE | 2 | N | 260017408 | CHOP |
| 260018266 | 260010241 | 1.81 | 46 | Curative (C) | 2017-02-27 | 2017-03-27 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | N | N | 260019019 | IFOSFAMIDE + PACLITAXEL |
| 260018267 | 260010244 | 1.81 | 67.4 | Curative (C) | 2020-04-05 | 2020-04-12 | Gemcitabine + Oxaliplatin | 2 | N | 260022120 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260018268 | 260014850 | 1.88 | 71.4 | Curative (C) | 2016-01-03 | 2016-03-21 | PEMBROLIZUMAB | N | N | 260022492 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260018269 | 260006451 | null | null | Palliative (P) | 2017-01-08 | 2017-02-25 | Rituximab (Maintenance) | N | N | 260010969 | RITUXIMAB |
| 260018270 | 260006462 | 1.84 | null | Disease modification (D) | 2016-03-20 | 2016-05-23 | Rituximab (Maintenance) | 02 | N | 260011567 | RITUXIMAB |
| 260018271 | 260006464 | null | null | Palliative (P) | 2017-02-25 | 2017-09-19 | Rituximab (INTRAVENOUS Maintenance) | N | N | 260011668 | RITUXIMAB |
| 260018272 | 260006468 | 1.71 | 47 | Not known (9) | 2016-03-25 | 2017-03-11 | Rituximab (Maintenance) | N | N | 260011994 | RITUXIMAB |
| 260018273 | 260012546 | 1.8 | null | Palliative (P) | 2018-12-24 | 2018-12-27 | Rituximab | 02 | N | 260012162 | RITUXIMAB |
| 260018274 | 260006479 | null | 67.9 | Palliative (P) | 2018-11-04 | 2018-11-10 | Rituximab | 02 | N | 260012548 | RITUXIMAB |
| 260018275 | 260006482 | 1.75 | 101.399 | Palliative (P) | 2015-01-21 | 2015-02-03 | Rituximab | 02 | N | 260012573 | RITUXIMAB |
| 260018276 | 260006490 | null | null | Palliative (P) | 2014-03-20 | 2014-03-20 | Rituximab | 02 | N | 260012676 | RITUXIMAB |
| 260018277 | 260006496 | 1.68 | null | Disease modification (D) | 2015-12-29 | 2018-02-05 | Rituximab | null | null | 260013256 | RITUXIMAB |
| 260018278 | 260006500 | 1.9 | 100.7 | Disease modification (D) | null | 2016-11-19 | Rituximab | N | N | 260013428 | RITUXIMAB |
| 260018279 | 260006526 | 1.67 | 94.4 | Disease modification (D) | 2012-10-21 | 2013-05-06 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260015308 | RITUXIMAB |
| 260018280 | 260006537 | 1.75 | 72.8 | Curative (C) | 2018-11-11 | 2018-11-20 | Rituximab | 02 | N | 260015544 | RITUXIMAB |
| 260018281 | 260015816 | null | null | Disease modification (D) | 2016-10-28 | 2017-08-02 | Rituximab (Maintenance) | N | N | 260015694 | RITUXIMAB |
| 260018282 | 260006563 | null | 79.2 | Adjuvant (A) | null | 2018-01-18 | Rituximab | N | N | 260015829 | RITUXIMAB |
| 260018283 | 260006566 | 1.78 | 78.6 | Disease modification (D) | null | 2018-01-17 | Rituximab (Maintenance) | N | N | 260015840 | RITUXIMAB |
| 260018284 | 260006567 | 1.65 | 64.6 | Palliative (P) | null | 2018-06-12 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260015845 | RITUXIMAB |
| 260018285 | 260006596 | 0 | 52.45 | Adjuvant (A) | 2012-12-15 | 2014-03-20 | Rituximab (Maintenance) | N | N | 260016181 | RITUXIMAB |
| 260018286 | 260006601 | null | 65.3 | Disease modification (D) | 2016-04-24 | 2016-06-29 | Rituximab (INTRAVENOUS Maintenance) | N | N | 260016233 | RITUXIMAB |
| 260018287 | 260012645 | 1.78 | 62 | Disease modification (D) | 2019-05-30 | 2019-06-01 | Rituximab | 02 | N | 260016286 | RITUXIMAB |
| 260018288 | 260006612 | 1.85 | 0 | Curative (C) | 2015-02-09 | 2015-04-22 | Rituximab (Maintenance) | N | N | 260016314 | RITUXIMAB |
| 260018289 | 260006618 | 1.69 | 60 | null | 2015-07-11 | 2016-01-06 | Rituximab | 02 | N | 260016358 | RITUXIMAB |
| 260018290 | 260006628 | 0 | 92.1 | Disease modification (D) | 2015-03-10 | 2015-11-13 | Rituximab | N | N | 260016457 | RITUXIMAB |
| 260018291 | 260006663 | 1.87 | 137 | Disease modification (D) | 2019-05-05 | 2019-05-12 | Rituximab (Maintenance) | N | N | 260016796 | RITUXIMAB |
| 260018292 | 260006667 | 1.81 | 82.9 | Palliative (P) | 2017-08-22 | 2017-09-18 | Rituximab | 2 | N | 260016818 | RITUXIMAB |
| 260018293 | 260006669 | 1.71 | 64 | Disease modification (D) | 2014-05-24 | 2014-05-31 | Rituximab (Maintenance) | 02 | N | 260016849 | RITUXIMAB |
| 260018294 | 260006698 | 1.7 | 0 | Palliative (P) | 2014-08-04 | 2014-08-14 | Rituximab (Maintenance) | 02 | N | 260017136 | RITUXIMAB |
| 260018295 | 260012731 | 1.67 | 78 | Disease modification (D) | 2016-11-14 | 2017-04-28 | Rituximab | N | N | 260017425 | RITUXIMAB |